News: ICD-10-PCS new proposals now available for public review and comments
The CDC National Center for Health Statistics discussed 31 proposals involving procedure code topics at a public ICD-10 Coordination and Maintenance Committee Meeting held March 17–18, 2026. Of the 31 proposals, 22 either have a NTAP application submitted for fiscal year 2027 consideration or have an application in the process of being submitted.
The public has until May 15, 2026, to submit comments on the updates proposed for implementation, which would begin on April 1, 2027.
Only two of the proposals are unrelated to the X tables for new technology:
- Division of mitral valve leaflets during transcatheter mitral valve replacement.
Left ventricular outflow tract (LVOT) obstruction is a life-threatening complication of transcatheter mitral valve replacement (TMVR). It occurs when the anterior leaflet of the mitral valve is displaced toward the interventricular septum by the newly implanted transcatheter device, severely narrowing or occluding the outflow tract.
Currently, there is no unique ICD-10-PCS code to describe the division of mitral valve leaflets used during transcatheter mitral valve replacement to prevent LVOT obstruction. It is currently coded as follows:
- For the division of mitral valve leaflets, coders are to use table 02Q for Repair of Heart and great vessels and report a code with body part value Mitral valve (G), approach value Percutaneous (3), and qualifier value No qualifier (Z)
- For the TMVR, coders are to use table 02R for Replacement of Heart and great vessels, with body part value Mitral valve (G), the applicable device value, and approach value Percutaneous (3)
To more accurately report the division of mitral valve leaflets, it has been proposed to create a code in table 028 for Division of Heart and great vessels, adding new body part value Mitral valve (G) and new qualifier value Leaflet laceration technique (0). The TMVR procedure would still be reported the same way as listed above.
- Retinal angiography using fluorescing agent
Both the retina and the choroid, the pigmented vascular layer of the eyeball between the retina and the sclera, receive their blood supply from the ophthalmic artery, which is the first branch of the internal carotid artery. Fluorescein angiography is an ophthalmic diagnostic procedure which uses fluorescent dye and rapid photography to visualize blood flow in the retina and choroid with special ophthalmic camera systems.
Facilities can currently report the retinal angiography using table 08J for Inspection of Eye and report the administration of the fluorescein using table 3E0 for Introduction to Physiological systems and anatomical regions.
It has been proposed to create new table B85 for Other imaging of Eye with available body part values including Choroid, right (A); Choroid, left (B); Retinal vessel, right (G); and Retinal vessel, left (H). To specifically report the fluorescing agent, a new fifth character Fluorescing agent (2) would be available.
Editor’s note: To read the full set of proposals, click here. To read additional coverage from JustCoding, click here.